WeChat Mini Program
Old Version Features

An Open-Label Randomised-Controlled Trial of Azathioprine Vs. Mycophenolate Mofetil for the Induction of Remission in Treatment-Naive Autoimmune Hepatitis

Romee J. A. L. M. Snijders,Anna E. C. Stoelinga,Tom J. G. Gevers,Simon Pape,Maaike Biewenga,Maarten E. Tushuizen,Robert C. Verdonk,Hendrik J. M. de Jonge,Jan Maarten Vrolijk,Sjoerd F. Bakker,Thomas Vanwolleghem,Ynto S. de Boer,Martine A. M. C. Baven Pronk,Ulrich Beuers,Adriaan J. van der Meer,Nicole M. F. van Gerven,Marijn G. M. Sijtsma,Brechje C. van Eijck,Manon C. van Ijzendoorn,Margot van Herwaarden,Floris F. van den Brand,Kerem Sebib Korkmaz,Aad P. van den Berg,Maureen M. J. Guichelaar,Amar D. Levens,Bart van Hoek,Joost P. H. Drenth

JOURNAL OF HEPATOLOGY（2024）

Cited 15|Views55
Key words
autoimmune hepatitis,azathioprine,mycophenolate mofetil,first-line treatment,induction therapy,randomised-controlled trial,remission,biochemical remission,phase IV trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined